Quantum dots and prion proteins Is this a new challenge for neurodegenerative diseases imaging?

článek v časopise ve Web of Science, Jimp

angličtina

A diagnostics of infectious diseases can be done by the immunologic methods or by the amplification of nucleic acid specific to contagious agent using polymerase chain reaction. However, in transmissible spongiform encephalopathies, the infectious agent, prion protein (PrPSc), has the same sequence of nucleic acids as a naturally occurring protein. The other issue with the diagnosing based on the PrPSc detection is that the pathological form of prion protein is abundant only at late stages of the disease in a brain. Therefore, the diagnostics of prion protein caused diseases represent a sort of challenges as that hosts can incubate infectious prion proteins for many months or even years. Therefore, new in vivo assays for detection of prion proteins and for diagnosis of their relation to neurodegenerative diseases are summarized. Their applicability and future prospects in this field are discussed with particular aim at using quantum dots as fluorescent labels.

imaging; label; neurodegenerative disease; prion protein; quantum dots

ŠOBROVÁ, P.; BLAŽKOVÁ, I.; CHOMOUCKÁ, J.; DRBOHLAVOVÁ, J.; VACULOVIČOVÁ, M.; KOPEL, P.; HUBÁLEK, J.; KIZEK, R.; ADAM, V.

2013

1. 9. 2013

LANDES BIOSCIENCE

1806 RIO GRANDE ST, AUSTIN, TX 78702 USA

1933-6896

PRION

7

5

Spojené státy americké

349

358

10